ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,604Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 761

$599K Total Retail Price of All Prescriptions

Rank: 73 out of 761

726 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 726 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 726 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 10,705 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 669 617 1 3
LISINOPRIL 520 476 2 1
SIMVASTATIN 494 461 3 2
AMLODIPINE BESYLATE 367 358 4 6
OMEPRAZOLE 345 311 5 4
ZOLPIDEM TARTRATE 316 308 6 22
CITALOPRAM HBR 313 294 7 19
FUROSEMIDE 281 253 8 7
ATENOLOL 269 247 9 8
LOVASTATIN 265 243 10 17
TRAZODONE HCL 258 242 11 23
HYDROCHLOROTHIAZIDE 218 210 12 11
ALENDRONATE SODIUM 212 212 13 21
HYDROCODONE-ACETAMINOPHEN 204 189 S3 14 5
METOPROLOL TARTRATE 193 189 15 14
GABAPENTIN 169 141 16 15
METFORMIN HCL 162 152 17 10
WARFARIN SODIUM 153 153 18 9
ATORVASTATIN CALCIUM 136 129 19 12
SERTRALINE HCL 127 102 20 25
TRAMADOL HCL 121 116 21 34
PANTOPRAZOLE SODIUM 120 116 22 40
LOSARTAN POTASSIUM 118 118 23 13
POTASSIUM CHLORIDE 114 100 24 18
QUETIAPINE FUMARATE 110 107 25 90
PAROXETINE HCL 106 97 26 47
MIRTAZAPINE 104 98 27 50
DONEPEZIL HCL 103 102 28 33
TRIAMTERENE-HCTZ 103 103 28 42
PREMARIN 102 98 R 30 88
FLUTICASONE PROPIONATE 95 78 31 29
CIPROFLOXACIN HCL 94 87 32 63
PRAVASTATIN SODIUM 90 80 33 20
POLYETHYLENE GLYCOL 3350 88 86 34 62
ESTRADIOL 87 75 R 35 80
PROAIR HFA 86 68 36 32
METOPROLOL SUCCINATE 86 86 36 16
ALLOPURINOL 85 82 38 28
ESCITALOPRAM OXALATE 85 83 38 102
GLYBURIDE 74 74 R 40 77
CARVEDILOL 74 74 40 26
CRESTOR 73 73 42 36
DIOVAN 72 65 43 58
CYMBALTA 65 59 44 53
VENLAFAXINE HCL ER 63 47 45 76
NAMENDA 63 63 45 59
DIGOXIN 61 61 47 43
NITROFURANTOIN MONO-MACRO 61 60 47 207
FLUOXETINE HCL 61 50 47 31
PRAMIPEXOLE DIHYDROCHLORIDE 57 55 50 141
FENOFIBRATE 56 46 51 91
ENALAPRIL MALEATE 51 51 52 71
OXYBUTYNIN CHLORIDE ER 50 50 53 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.